Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
59.7%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 3.04Close
$ 0.42 - $ 4.74 52-Week Range
Ticker Information
Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABVC BIOPHARMA INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABVC - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 233.56K | 59.7% | $ 391.24K |
| 3/31/2025 | $ 364.18K | 71.64% | $ 508.38K |
| 12/31/2024 | $ 825.9K | 162.07% | $ 509.59K |
| 9/30/2024 | $ 2.27M | 444.8% | $ 509.79K |
| 6/30/2024 | $ 3.27M | 2394.97% | $ 136.4K |
| 3/31/2024 | $ 3.12M | 12306.75% | $ 25.36K |
| 12/31/2023 | $ 2.49M | 1635.73% | $ 152.43K |
| 9/30/2023 | $ 1.52M | 206.22% | $ 739.26K |
| 6/30/2023 | $ 432.41K | 56.48% | $ 765.64K |
| 3/31/2023 | $ 332.42K | 31% | $ 1.07M |
Key Performance Insights, Last 5 Years
- ABVC BIOPHARMA INC's latest trailing twelve months (TTM) Int. Exp. % stands at 63.86%.
- Over the past 5 years, ABVC BIOPHARMA INC's average Int. Exp. % has been 1174.14%.
- The median Int. Exp. % for ABVC BIOPHARMA INC during this period was 71.64%
- ABVC BIOPHARMA INC reached its highest Int. Exp. % over the past 5 years at 12306.75%.
- The lowest Int. Exp. % recorded by ABVC BIOPHARMA INC in the same timeframe 11.83%
ABVC BIOPHARMA INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for ABVC BIOPHARMA INC is calculated as follows: Int. Exp. [ $ 227.21K ] / Revenues [ $ 355.8K ]
(=) Int. Exp. % [ 63.86% ] ABVC - Interest Expense Margin, Last 5 years
11.83%
Minimum
Jun 30, 2022
12306.75%
Maximum
Mar 31, 2024
1174.14%
Average
71.64%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |